In vitro activity of telithromycin (HMR3647), a new ketolide, aganst clinical isolates of Mycoplasma pneumoniae in Japan

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 5, 2000, Pages 1381-1382

  Yamaguchi, Toshiyuki ^a   Hirakata, Yoichi ^a   Izumikawa, Koichi ^a   Miyazaki, Yoshitsugu ^a   Maesaki, Shigefumi ^a   Tomono, Kazunori ^a   Yamada, Yasuaki ^a   Kamihira, Shimeru ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; ERYTHROMYCIN; JOSAMYCIN; KETOLIDE; MACROLIDE; ROXITHROMYCIN; TELITHROMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; DRUG POTENCY; IN VITRO STUDY; JAPAN; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; HUMANS; JAPAN; KETOLIDES; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA PNEUMONIAE;

EID: 0034090751     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.5.1381-1382.2000     Document Type: Article

References (15)

1. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1998. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). Antimicrob. Agents Chemother. 42:945-946.
2. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1998. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. Antimicrob. Agents Chemother. 42:2138-2140.
3. Chanock, R. M., L. Hayflick, and M. F. Barile. 1962. Growth on artificial medium of an agent associated with atypical pneumonia and its identification as PPLO. Proc. Natl. Acad. Sci. USA 48:41-49.
4. Edelstein, P. H., and M. A. Edelstein. 1999. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia. Antimicrob. Agents Chemother. 43:90-95.
5. Hamilton-Miller, J. M., and S. Shah. 1998. Comparative in-vitro activity of ketolide HMR 3647 and four macrolides against gram-positive cocci of known erythromycin susceptibility status. J. Antimicrob. Chemother. 41:649-653.
6. Ishida, K., M. Kaku, K. Irifune, R. Mizukane, H. Takemura, R. Yoshida, H. Tanaka, T. Usui, N. Suyama, K. Totnono, H. Koga, S. Kohno, K. Izumikawa, and K. Hara. 1994. In vitro and in vivo activities of macrolides against Mycoplasma pmumoniae. Antimicrob. Agents Chemother. 4:790-798.
7. Ishida, T., T. Hashimoto, M. Arita, I. Ito, and M. Osawa. 1998. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 114:1588-1593.
8. Izumikawa, K., Y. Hirakata, T. Yamaguchi, R. Yoshida, H. Tanaka, H. Takemura, S. Maesaki, K. Tomono, M. Kaku, K. I. Izumikawa, S. Kamihira, and S. Kohno. 1998. In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 42:698-699.
9. Kaku, M., K. Ishida, K. Irifune, K. Mizukane, H. Takemura, R. Yoshida, H. Tanaka, T. Usui, K. Tomono, N. Suyama, H. Koga, S. Kohno, and K. Hara. 1994. In vitro and in vivo activities of sparfloxacin against Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 4:738-741.
10. Lucier, T. S., K. Heitzman, S. K. Liu, and P. C. Hu. 1995. Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 12:2770-2773.
11. Malathum, K., T. M. Coque, K. V. Singh, and B. E. Murray. 1999. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria. Antimicrob. Agents Chemother. 43:930-936.
12. Osada, Y., and H. Ogawa. 1983. Antimycoplasmal activity of ofloxacin (DL-8280). Antimicrob. Agents Chemother. 23:509-511.
13. Piper, K. E., M. S. Rouse, J. M. Steckelberg, W. R. Wilson, and R. Patel. 1999. Ketolide treatment of Haemophilus influenzae experimental pneumonia. Antimicrob. Agents Chemother. 43:708-710.
14. Waites, K. B., G. H. Cassel, K. C. Canupp, and P. B. Fernandes. 1988. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones. Antimicrob. Agents Chemother. 32:1500-1502.
15. Waites, K. B., L. B. Duffy, T. Schmid, D. Crabb, M. S. Pate, and G. H. Cassel. 1991. In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob. Agents Chemother. 35:1181-1185.